A new risk stratification model for idiopathic pulmonary fibrosis could shift treatment from passive monitoring to active, goal-oriented care.

In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.

Recommendations are presented for the primary care management of asthma in veterans and military members in a synopsis of a clinical practice guideline.

Insufficient evidence exists to show efficacy of novel hypersensitivity pneumonitis therapies, indicating the need for clinical protocols.

“Our results suggest that oscillometry . . . may serve as valuable, noninvasive biomarkers for early detection, risk stratification, and longitudinal monitoring of IPF,” the authors concluded.

High-flow nasal cannula (HFNC) oxygenation may be superior to conventional oxygen therapy for high-risk patients undergoing bronchoscopy.

For patients aged 5 to 25 years, allergic conjunctivitis is associated with increased risk for keratoconus and increased corneal diagnostic procedures.

Heart Failure Society of America and AAHFN released a joint scientific statement about integrated health technologies in heart failure.

Wastewater detection of wild-type measles virus preceded the initial reported case in Oregon in 2024 by 10 weeks, according to an MMWR report.

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...

Measuring DLL3 expression via circulating tumor cells (CTCs) may help predict which patients with ES-SCLC will respond to tarlatamab.

Testing for respiratory syncytial virus (RSV) in outpatient settings is low overall among adults in the United States.